Skip to content
OpenCapital
Get started

Astrana Health ASTH Net Income Loss Including Portion Attributable To Noncontrolling Interest And Temporary Equity

Other financials

Income statement

See full
Revenue$965.1M+55.6%
Gross profit$105.7M+48.2%
Operating income$28.5M+38.6%
Net income$14.4M+116%
EPS (diluted)$0.29+107%

Balance sheet

See full
Cash & equivalents$478.4M+85.0%
Total debt$1.1B+136%
Total equity$800.3M+7.4%
Total assets$2.4B+77.2%

Cash flow

See full
Operating cash flow$68.1M+309%
CapEx$4.0M+30.3%
Free cash flow$64.1M+372%

Valuation

See full
Market cap$2.1B-3.0%

Profitability

See full
Gross margin10.7%-1.3pp
Operating margin2.5%-1.1pp
Net margin0.9%—
FCF margin4.6%—

Returns & leverage

See full
Return on equity3.9%—
Debt / equity1.3×+0.7×
Current ratio1.3×-0.4×

Where this comes from

Reported directly by Astrana Health in its filing.

Tagged under the XBRL concept asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity.

The official record: Astrana Health’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Astrana Health's net income loss including portion attributable to noncontrolling interest and temporary equity?
Astrana Health (ASTH) reported net income loss including portion attributable to noncontrolling interest and temporary equity of $15.81M in Q1 2026.
How has Astrana Health's net income loss including portion attributable to noncontrolling interest and temporary equity changed year-over-year?
Astrana Health's net income loss including portion attributable to noncontrolling interest and temporary equity increased by 103.1% year-over-year, from $7.79M to $15.81M.